Thanks Papa,
That was a really good interview. I don’t think there was anything not aligned to what I currently think about how things are running for the company.
I also think we are lucky to have a very experienced CEO that has actually achieved a multi-billion dollar Pharma deal & brought drugs to commercialisation in his career.
Add on a PhD in clinical trial design & a clinical Specialist, a lot of confidence right there. I don’t know about this ‘Rock Star’ BS, Dr G comes across as a very down to earth & humble CEO - positive vibes, which may not mean anything to some people.
Lastly $15.2 million in the bank which will fund all of the current trials. Fragile X has been awarded Rare Paediatric Disease status by the FDA (accelerated pathway).
Take a look at Rare Disease/Orphan status drugs, if you are not familiar with this pathway & the benefits to companies who develop orphan drugs.
We just await the 3rd “mystery trial”. This is interesting because schizophrenia/MH & diabetes have been discussed previously. Has this changed?
Just FYI Boehringer’s IND for cognitive impairment in schizophrenia has received breakthrough therapy designation with the FDA (accelerated pathway also).
https://www.prnewswire.com/news-releases/boehringer-ingelheims-investigational-treatment-for-cognitive-impairment-associated-with-schizophrenia-receives-fda-breakthrough-therapy-designation-301297651.html
Sounds like maybe & depression/anxiety & PTSD are some other things being discussed by SH here. I think maybe we are going to see something very interesting drop on news from the ‘mystery trial’ & the reason they haven’t yet informed us?
GLTAH
- Forums
- ASX - By Stock
- Under valued stock
Thanks Papa, That was a really good interview. I don’t think...
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.002(6.67%) |
Mkt cap ! $74.60M |
Open | High | Low | Value | Volume |
3.0¢ | 3.2¢ | 2.8¢ | $52.54K | 1.749M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11059 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 154422 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11059 | 0.030 |
2 | 681037 | 0.028 |
3 | 258348 | 0.027 |
4 | 235771 | 0.026 |
9 | 1150000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 154422 | 2 |
0.033 | 165000 | 2 |
0.034 | 364516 | 2 |
0.035 | 352280 | 5 |
0.036 | 86361 | 2 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
3.1¢ |
  |
Change
0.002 ( 6.90 %) |
|||
Open | High | Low | Volume | ||
2.9¢ | 3.1¢ | 2.9¢ | 855992 | ||
Last updated 15.54pm 28/03/2024 ? |
Featured News
ACW (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online